NSE: SUDEEPPHRM
SUDEEP PHARMA LIMITED
Price history
+64.81% over 3M
Performance
52-week range
Position in day range
SUDEEPPHRM stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹1,018.31
RSI (14)
60
Neutral momentum
Volatility (ATR)
5.08%
High
Close streak
3d down
Volume vs 20d avg
2.38x
Unusual activity
From 52W high
-12.71%
Up from 52W low
+129.52%
Green days (20)
11/20
Monthly seasonality
Average monthly move for SUDEEPPHRM across the available price history.
Key statistics
Open
1,152.9
Day high
1,244
Day low
1,152.9
Prev close
1,202.8
Volume
5.93 L
Avg vol (20d)
2.49 L
52W high
1,378
52W low
524.05
SUDEEPPHRM quarterly results
All SUDEEPPHRM results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹158 cr
+26.7% YoY
Net profit
₹40.55 cr
+31.6% YoY
Operating profit
₹50.91 cr
+25.3% YoY
EPS
₹3.59
+31.6% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹158 cr | ₹50.91 cr | ₹40.55 cr | 32.2% | 25.6% | ₹3.59 | +31.6% | -17.0% |
| Q4 FY262026-03-31 | ₹182 cr | ₹58.71 cr | ₹48.88 cr | 32.2% | 26.8% | — | +10.6% | +3.0% |
| Q3 FY262025-12-31 | ₹172 cr | ₹56.11 cr | ₹47.46 cr | 32.6% | 27.5% | ₹4.29 | — | +54.1% |
| Q1 FY262025-06-30 | ₹125 cr | ₹40.62 cr | ₹30.81 cr | 32.5% | 24.7% | ₹2.73 | — | -30.3% |
| Q4 FY252025-03-31 | ₹158 cr | ₹55.95 cr | ₹44.19 cr | 35.5% | 28.0% | — | — | — |
| TTM (last 4 quarters) | ₹638 cr | ₹206 cr | ₹168 cr | 32.4% | 26.3% | — | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
SUDEEPPHRM Hits 52-Week High, Up 2.75%: Inside the Momentum Story Moving Sudeep Pharma Shares
Sudeep Pharma (SUDEEPPHRM) trades at ₹1,329.30, +36.50 (+2.75%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Why Sudeep Pharma Share Price Hits 52-Week High, Up 2.75% Today: the Momentum Trigger, Explained
Sudeep Pharma (SUDEEPPHRM) trades at ₹1,329.30, +36.50 (+2.75%) as the momentum story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Latest market news
Solar Industries (I) Share Price Trades Flat at ₹22,290.00: What Is Driving SOLARINDS Today, and the Levels That Matter
Solar Industries (I) (SOLARINDS) trades at ₹22,290.00, -80.00 (-0.36%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Jubilant Pharmova Share Price Trades Flat at ₹1,025.20 Today — Volumes, 52-Week Range and What to Watch Next
Jubilant Pharmova (JUBLPHARMA) trades at ₹1,025.20, -0.45 (-0.04%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Coforge Share Price Opens Gap-Down at ₹1,807.30: What Is Driving COFORGE Today, and the Levels That Matter
Coforge (COFORGE) trades at ₹1,846.50, +13.40 (+0.73%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Aavas Financiers Share Price Edges Lower to ₹1,271.50 Today — Volumes, 52-Week Range and What to Watch Next
Aavas Financiers (AAVAS) trades at ₹1,271.50, -14.60 (-1.15%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Morning Market Buzz, 12 September 2026: IPOs Tops the Coverage Ahead of Policy And Macro Data and Banks And NBFCs
The most-covered market themes in the morning session on 12 September 2026 — IPOs, policy and macro data, banks and NBFCs — with our live numbers for each and links to the publishers running the story.
Raymond Share Price Hits 52-Week High, Up 14.85%: What Is Driving RAYMOND Today, and the Levels That Matter
Raymond (RAYMOND) trades at ₹1,002.80, +148.95 (+14.85%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.